Abstract
Malaria anaemia is still a major killer of children in malaria endemic countries. We have shown from the published literature that malaria anaemia, especially mild to moderate anaemia is largely due to inflammation-induced hypoferreamia and immune-mediated destruction of parasitized and non-parasitized red blood cells. In this review, we speculate that the immunomodulatory and anti-inflammatory properties of chloroquine, a cheap, readily available antimalarial, may make it a very good candidate for investigation as a possible adjunct treatment for malariaassociated anaemia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
